Sat, Dec 27, 2014, 9:05 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

  • chimakot chimakot Jul 31, 2013 12:16 PM Flag

    Former United States Securities and Exchange Commission attorney Willie Briscoe .....

    This deal is rotten to the core and the stench can be smelled all the way from NY to Texas. Let's ride!

    Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor, LLP are investigating the sale of Trius Therapeutics, Inc. (“Trius”) (TSRX) to Cubist Pharmaceuticals, Inc. for shareholders. Under the terms of the proposed merger agreement, valued at approximately $818 million, Trius shareholders will receive only $13.50 in cash and one Contingent Value Right for each share of Trius stock owned, well below at least one analyst’s estimated value of $20.00.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
TSRX
13.630.0000(0.00%)Sep 11 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
Westar Energy, Inc.
NYSEFri, Dec 26, 2014 4:07 PM EST
Thor Industries Inc.
NYSEFri, Dec 26, 2014 4:09 PM EST